Category: Peptide Q&A
-
Does MOTS-c influence neurogenesis in the hippocampus, and what animal models support this?
Does MOTS-c influence neurogenesis in the hippocampus, and what animal models support this?
-
How does MOTS-c affect insulin secretion from pancreatic beta cells, and is this effect direct or indirect?
How does MOTS-c affect insulin secretion from pancreatic beta cells, and is this effect direct or indirect?
-
Are there biomarkers that can be used to monitor MOTS-c’s biological activity in humans?
Are there biomarkers that can be used to monitor MOTS-c’s biological activity in humans?
-
Is MOTS-c safe for use in individuals with autoimmune conditions or chronic inflammation?
Is MOTS-c safe for use in individuals with autoimmune conditions or chronic inflammation?
-
What are the limitations of existing studies on MOTS-c, particularly regarding sample size and duration?
What are the limitations of existing studies on MOTS-c, particularly regarding sample size and duration?
-
Does MOTS-c improve mitochondrial function in aging skeletal muscle, and what biomarkers support this?
Does MOTS-c improve mitochondrial function in aging skeletal muscle, and what biomarkers support this?
-
How does MOTS-c compare to caloric restriction or exercise in enhancing mitochondrial function and metabolic health?
How does MOTS-c compare to caloric restriction or exercise in enhancing mitochondrial function and metabolic health?
-
Is there evidence that MOTS-c reduces neuroinflammation in models of aging or neurodegeneration?
Is there evidence that MOTS-c reduces neuroinflammation in models of aging or neurodegeneration?